MannKind | SKULD



Debt Ändra Datum
Adma Biologics USD 72.34M 28.99M 2024-12
Dynavax Technologies USD 260.51M 36.65M 2025-03
Eli Lilly USD 38.52B 4.87B 2025-03
Halozyme Therapeutics USD 1.51B 1.65M 2025-03
Insmed USD 1.13B 147.86M 2024-12
MacroGenics USD 0 0 2024-12
MannKind USD 289.64M 191.38M 2024-12
Merck USD 34.84B 2.27B 2025-03
Novo Nordisk DKK 56.97B 88M 2024-09
Pfizer USD 62.11B 2.24B 2025-03
Sanofi 21.05B 3.14B 2025-03
Xencor USD 163.61M 145.69M 2024-12



MannKind SKULD - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - May 2025.